These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 15303439)
1. [Guidelines for the treatment of lung cancer with lymph node involvement]. Ikeda N; Tsuboi M; Ohira T; Hirano T; Kato H Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):404-7. PubMed ID: 15303439 [TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Tieu BH; Sanborn RE; Thomas CR Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609 [TBL] [Abstract][Full Text] [Related]
3. [Multimodal treatment of non small cell lung cancer]. Stoelben E; Digel W; Henke M; Passlick B Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776 [TBL] [Abstract][Full Text] [Related]
4. [Surgical strategy for stage III non-small cell lung cancer; a review based on our experience and the literature]. Horio H Gan To Kagaku Ryoho; 2007 Jun; 34(6):836-40. PubMed ID: 17565243 [TBL] [Abstract][Full Text] [Related]
5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
6. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079 [TBL] [Abstract][Full Text] [Related]
7. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis]. Huang GJ; Fang DK; Cheng GY; Zhang DC Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625 [TBL] [Abstract][Full Text] [Related]
8. [The role of adjuvant therapy in the management of pN2 non-small-cell carcinoma of the lung]. Chella A; Lucchi M; Gragnani F; Ribechini A; Silvano G; Janni A; Mussi A; Angeletti CA Minerva Chir; 1995 Dec; 50(12):1029-38. PubMed ID: 8725059 [TBL] [Abstract][Full Text] [Related]
9. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer]. Yu DP; Bai LQ; Xu SF; Han M; Wang ZT Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561 [TBL] [Abstract][Full Text] [Related]
10. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer. Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281 [No Abstract] [Full Text] [Related]
11. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy]. Watanabe Y Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413 [TBL] [Abstract][Full Text] [Related]
12. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer. Maas KW; El Sharouni SY; Smit EF; Schramel FM Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176 [TBL] [Abstract][Full Text] [Related]
13. [Adhesion or organization during surgery due to mediastinoscopy before induction therapy for non-small cell lung cancer]. Sawabata N; Maeda H; Takeda S; Inoue M; Okumura Y; Asada H Kyobu Geka; 2003 Jun; 56(6):441-4. PubMed ID: 12795146 [TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)]. Eberhardt W Praxis (Bern 1994); 1997 Oct; 86(42):1647-53. PubMed ID: 9432686 [TBL] [Abstract][Full Text] [Related]
15. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H; J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093 [TBL] [Abstract][Full Text] [Related]
16. [Multimodality treatment for non-small cell lung cancer from the surgical standpoint]. Tada H Gan To Kagaku Ryoho; 1998 Jan; 25(2):225-31. PubMed ID: 9474932 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [TBL] [Abstract][Full Text] [Related]
18. Current treatment recommendations for stage III non-small-cell lung carcinoma. Davis MP; Sause WT Clin Adv Hematol Oncol; 2003 Oct; 1(10):587-93. PubMed ID: 16258455 [TBL] [Abstract][Full Text] [Related]
19. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer]. Hennequin C; Girard N; Mornex F Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307 [TBL] [Abstract][Full Text] [Related]
20. Surgical management of non-small cell lung cancer with mediastinal lymphadenopathy. Rocco G; Perrone F; Rossi A; Gridelli C Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):325-33. PubMed ID: 20156672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]